Quark Pharmaceuticals Competitors and Similar CompaniesClear all
Quark Pharmaceuticals's competitors and similar companies include Actinium Pharmaceuticals, ImmuPharma, LabConnect and Cambridge Epigenetix.
 Quark Pharmaceuticals Quark Pharmaceuticalsis a clinical-stage pharmaceutical company engaged in the discovery and development of novel RNAi-based therapeutics. |  Actinium Pharmaceuticals Actinium Pharmaceuticals is a biopharmaceutical company developing targeted payload immunotherapeutics for the treatment of advanced cancers. |  ImmuPharma ImmuPharma is a pharmaceutical company focused on developing innovative drugs to treat serious medical conditions in specialist therapeutic areas. |  LabConnect LabConnect is a provider of central laboratory support services for analytically and logistically complex studies such as immuno-oncology, cell and gene therapies, and rare and orphan diseases. |  Cambridge Epigenetix Cambridge Epigenetix (also known as CEGX) is a bioscience company that uses epigenetics to reduce several routine & important diagnostic tests for common cancers to a simple blood draw. | |
Founding Date | Founding Date 1994 | Founding Date 2000 | Founding Date 1999 | Founding Date 2002 | Founding Date 2012 |
Type | Type Private | Type Public | Type Public | Type Private | Type Private |
Tags | |||||
Locations | Locations Newark, US HQ | Locations New York, US HQ | Locations London, GB HQ Mulhouse, FR Sarnen, CH London, GB | Locations Johnson City, US HQ Buenos Aires, AR Sydney, AU Minsk, BY Tbilisi, GE Mumbai, IN Tel Aviv Yafo, IL see more | Locations Little Chesterford, GB HQ Wilmslow, GB |
Employees | Employees 781% decrease | Employees 2517% decrease | Employees 5 | Employees 1961% decrease | Employees 1121% decrease |
Valuation ($) | Valuation ($) N/A | Valuation ($) 58.6 m | Valuation ($) 8.6 m | Valuation ($) N/A | Valuation ($) N/A |
Financial | |||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) $90k (FY, 2025) | Revenue (est.) N/A | Revenue (est.) N/A | Revenue (est.) N/A |
Net income | Net income N/A | Net income N/A | Net income (£2.5m) (FY, 2024) | Net income N/A | Net income (£86.2k) (FY, 2012) |
Funding | |||||
Latest funding round | Latest funding round $ 10m (almost 16 years ago) | Latest funding round N/A | Latest funding round N/A | Latest funding round $ 24.5m (almost 9 years ago) | Latest funding round $ 30m (about 8 years ago) |
Total funding raised | Total funding raised $ 37m | Total funding raised $ 7m | Total funding raised N/A | Total funding raised $ 28.5m | Total funding raised $ 56.5m |
For sources of this data, please see the company profile
View Company Profiles
Actinium Pharmaceuticals
HQ
New York, US
Employees
25↓ 17% decrease
Actinium Pharmaceuticals is a biopharmaceutical company developing targeted payload immunotherapeutics for the treatment of advanced cancers.
View companyImmuPharma
HQ
London, GB
Employees
5
ImmuPharma is a pharmaceutical company focused on developing innovative drugs to treat serious medical conditions in specialist therapeutic areas.
View companyLabConnect
HQ
Johnson City, US
Employees
196↓ 1% decrease
LabConnect is a provider of central laboratory support services for analytically and logistically complex studies such as immuno-oncology, cell and gene therapies, and rare and orphan diseases.
View companyCambridge Epigenetix
HQ
Little Chesterford, GB
Employees
112↓ 1% decrease
Cambridge Epigenetix (also known as CEGX) is a bioscience company that uses epigenetics to reduce several routine & important diagnostic tests for common cancers to a simple blood draw.
View company